A. Ektesabi PhD

I am a translational scientist and entrepreneur working at the intersection of omics, clinical research, diagnostics, and RNA therapeutics. My background spans both discovery science and applied research, with a focus on turning complex biological and clinical data into meaningful insight that supports diagnostics, translational strategy, and therapeutic development. Public profiles tied to my work identify my University of Toronto background, my focus on cardiometabolics and RNA therapeutics, and my role as a co-founder of NorthMiRs.

My experience includes supporting multiple research groups across diverse therapeutic areas, including sepsis, ARDS, COVID-19, myocardial infarction, obesity, schizophrenia, prostate cancer, and psoriasis. Across these areas, I have contributed to projects spanning molecular research, translational studies, clinical investigations, and data-driven interpretation. I have also been involved in the evaluation of diagnostic tools in clinical settings, giving me perspective not only on biological discovery, but also on how technologies perform in real-world healthcare environments.

In parallel, I have built a strong foundation in preclinical and translational development. NorthMiRs publicly describes my work as leading pre-clinical studies and contributing to regulatory preparation toward a Clinical Trial Application with Health Canada, while public Ted Rogers Centre materials describe NorthMiRs as developing RNA-based therapeutics for sepsis-induced cardiac dysfunction.

My technical background spans cell culture, fluorescence imaging, immunofluorescence, animal work, microarray analysis, and quantitative RT-PCR, alongside omics interpretation and translational analysis. Public research profiles show a record of 30+ publications and 200+ citations, reflecting work across both mechanistic and clinically relevant research questions.

At OMIXPRO, I bring together these different layers of experience: biological discovery, clinical study support, diagnostic evaluation, and computational interpretation. My goal is to help clients move from complex data to clear scientific direction, whether that means uncovering biomarkers, interpreting omics datasets, evaluating diagnostic opportunities, or shaping translational strategy from discovery toward application.